Mode
Text Size
Log in / Sign up
N/A N=155 Screening

Increasing African Immigrant Women's Participation in Breast Cancer Screening

Breast Cancer

Enrolled (actual)
155
Serious AEs
Results posted
Dec 2024
Primary outcome: Primary: Mammogram Intention — 1.90 score on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
African Immigrant Breast Cancer Education Program (Behavioral)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Icahn School of Medicine at Mount Sinai
Primary completion
Jun 2023

Outcome Measures

OutcomeResultp-value
PRIMARY
Mammogram Intention
1.90
PRIMARY
Mammogram Location and Appointment
55; 6
SECONDARY
Perceived Risk
32; 9; 15; 4; 2
SECONDARY
Comparison Perceived Risk
38; 17; 6
SECONDARY
Self-Efficacy for Mammography
40.83

Summary

New York City (NYC) is home to a large and diverse immigrant population. Many of these groups face significant barriers to preventive health care, including lack of insurance, poor health care access and language difficulties. Most African immigrant women are likely to live below the poverty line and have low health literacy, are less likely to have health insurance and visit a doctor, particularly for primary/preventive care. Without access to primary care, many preventive services, such as breast cancer screenings go unattended. The barriers and facilitators to breast cancer screening for other minority groups from underserved populations, such as African Americans and Latina women have been studied. Less is known about these for African immigrant women and how to most effectively engage their participation in regular screening. Data of over 2,000 African-born immigrants living in NYC show that 77% report not having health insurance; 75% do not have a primary care physician; and 57% have less than a high school education. As for cancer screening, when corrected for age, 44% have never had a mammogram. Through the study team's unique collaboration with the African Services Committee and the African Advisory Council of the Bronx, two non-governmental community-based service organizations, the study team is poised to have a significant impact on these immigrant women, who have emigrated from more than 20 countries in Africa. This is a population with great need for increased breast cancer knowledge, access to breast cancer screening, and basic medical care. The Health Belief Model (HBM) provides a framework for addressing cultural health barriers by positing that making a decision to engage in a health behavior is determined by weighing perceived threats versus benefits. The long term goal of the proposed project is to conduct a randomized clinical trial that tests the adapted intervention to increase breast cancer screening rates for African-born immigrants. In the short term, the study team plans to pursue the following specific aims: (1) Identify barriers and facilitators to breast cancer screening among African-born immigrants and (2) Culturally adapt and pilot test the Witness Project breast cancer education program for African-born women. Thus, the study team will culturally adapt an effective, innovative intervention to address this significant health disparity in African-born immigrant communities.

Eligibility Criteria

AIM 1:

Inclusion criteria in-depth interviews with leaders:

  • ≥ 18 years of age
  • Stakeholder/gatekeeper in the African immigrant community, and read and speak English or French.

Inclusion criteria for In-depth Interviews and Quantitative Surveys:

  • Women 40 years of age or older;
  • Born in Africa;
  • Speak English or French.

Exclusion Criteria

  • <18 years of age
  • Cannot read and speak English or French

AIM 2:

Inclusion Criteria

  • ≥ 38 years of age
  • Women born in Africa, and read and speak English or French.

Exclusion Criteria

  • <38 years of age
  • Cannot read and speak English or French
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04450264). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search